Skip to content
‹ Back to IndustriesSciences

How Science and Technology is Revolutionizing the Cannabis Industry

Cannabis development is highly attributed to plant breeding and targeted cultivation strategies. Crops themselves are entirely different from those in the 1970s, and we’ve learned a lot by fine-tuning our techniques. According to Anders Peterson, Cannabis Operations Specialist at InSpire Transpiration Solutions, science and technology have been game-changing for cannabis development. “We’ve been able to…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · · Cannabis
Share

Key takeaways

01

Cannabis development is highly attributed to plant breeding and targeted cultivation strategies.

02

Crops themselves are entirely different from those in the 1970s, and we’ve learned a lot by fine-tuning our techniques.

03

According to Anders Peterson, Cannabis Operations Specialist at InSpire Transpiration Solutions, science and technology have been game-changing for cannabis development.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Cannabis development is highly attributed to plant breeding and targeted cultivation strategies. Crops themselves are entirely different from those in the 1970s, and we’ve learned a lot by fine-tuning our techniques.

According to Anders Peterson, Cannabis Operations Specialist at InSpire Transpiration Solutions, science and technology have been game-changing for cannabis development.

“We’ve been able to collect a significant more amount of data and learn from it, even just over the past five years,” said Peterson. “Besides that, the technology used to create a controlled environment inside in terms of lighting, fertigation, HVAC, have allowed us to also optimize plant growth and production and efficiency in these spaces.

In the same ways that farmers learn over time what crops grow best in what areas, we learn to isolate environmental factors to optimize plant growth. Starting with data collection, we better understand what the plants need.

These developments have decreased the number of days plants take to reach maturity and, in turn, increased the number of harvests a year within greenhouses. Specifically, within InSprire Transpiration Solutions, technology has increased harvest cycles from four per year to six. Similar techniques are developing in outdoor cannabis development and production.

In addition to environmental developments, we have also seen cannabis development in the plants themselves through crop steering and breeding. In the 1970s, THC levels in cannabis plants consistently registered 8-12%. Nowadays, plants are testing in the range of 35 to 40% with some cultivars. That’s a significant increase. A lot of that is down to the changes in plant breeding. However, targeted cultivation strategies also contribute to that shift.

Video TranscriptExpand ↓

Hi, my name is Anders Peterson with InSpire Transpiration Solutions. I'm an indoor cannabis cultivator for the past 12 years and a cell molecular biologist. And today, the question is how was an increased understanding of technology and science changing the cannabis industry? Well, a better understanding of science and technology has changed the cannabis industry in a number of ways. And specifically, when it comes to cultivation, it has allowed us to optimize plant performance, including yield and secondary metabolite concentration like cannabinoids and terpenes. And it's allowed us to optimize the production of the plant, primarily in an indoor setting, but also in the field. And in greenhouses. An example of this in an indoor scenario is that with data collection, a better understanding of the levers to pull for cultivation in terms of the Cardinal parameters of plant growth, we've been able to shorten cycle times and basically speed up plant growth so that we're getting additional harvests per year which is just increasing the bottom line for many of these cannabis cultivation businesses. For example, a while ago, an indoor flowering room would only get four harvest a year. Now we're shooting for getting six. So that's a significant more amount of product coming out of each space per year. All due to better understanding of science and technology. The advent of cheaper sensor technology and kind of the IOT of things has allowed us to learn a lot of these things that have, uh, you know, a lot of the parameters to optimize, because sensors have gotten so much cheaper more widely accessible. We've been able to collect a significant more amount of data and learn from it, even just over the past five years. Besides that, the technology used to create a controlled environment inside in terms of lighting, fertigation, HVAC, have allowed us to also optimize plant growth and production and efficiency in these spaces. So, really it's kind of changed the game, increasing, you know, a better understanding of technology and science. I'm looking forward to some really interesting research that's going to be coming out in the next year or so, that will even further optimize these indoor controlled environments, allowing us to reach new levels of plant performance in the cannabis crop that we've never seen before. I mean, just as a benchmark of back in the seventies, most cannabis dried flower tested in the THC percentages around eight to 12%. Nowadays, we're testing in the range of 35 to 40% with some cultivars. That's a significant increase. A lot of that is done through breeding, but also much more targeted cultivation strategy. That's allowed us to use techniques like crop steering, both in the irrigation side and in the environment that allow us to push the plant in certain predicted outcomes that are beneficial for the cultivator and for the crop. So it's really been quite amazing.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Merck KGaA moves Rapid Micro’s Growth Direct from distribution to ownership for QC labs

Merck KGaA moves Rapid Micro’s Growth Direct from distribution to ownership for QC labs

Merck KGaA agreed to buy Rapid Micro Biosystems, maker of the Growth Direct microbial testing platform, for $0.75 per share in cash. The deal turns a 2025 distribution partnership into ownership. Growth Direct instruments, consumables and software would then come from the company that already sells QC products to pharma labs, pending a December 2026 close.

  • 01Growth Direct shifts from a Merck-distributed product, under a February 2025 agreement, to a Merck-owned one inside a QC portfolio that spans environmental monitoring, in-process and release testing.
  • 02For labs that already run Growth Direct alongside MilliporeSigma QC products, the useful question is how the platform's digital sample records will connect to the rest of that workflow after close.
  • 03The next date to watch is the Schedule TO filing that opens the tender offer; closing targeted for December 2026 requires a majority of Rapid Micro’s voting shares to be tendered.

Nov 17, 2026

SR-Tiget gene therapy families average six months in Milan and years of lab tests

SR-Tiget gene therapy families average six months in Milan and years of lab tests

Gene therapy at Milan’s SR-Tiget includes a family support programme that helps relatives manage months-long stays (often around six months) for treatment, while a regulated lab can track patient samples for up to 20 years. Follow-up visits can outnumber new treatments, adding to the long-term workload.

  • 01In 2025, the programme logged 133 follow-up visits against 17 treatments; with roughly 15 years of twice-yearly checkups per patient, the follow-up load is likely to keep growing even if new treatments stay flat.
  • 02At SR-Tiget, the average family spends six months in Milan, and the child's samples can keep reaching the lab for as long as twenty years.
  • 03Any gene therapy service has to answer one question: who tells the lab when a child's fever pushes a blood draw from morning to afternoon? In Milan, research nurses own that handoff.

Nov 16, 2026

Two photonic AI components reach outside testers—limited access

Two photonic AI components reach outside testers—limited access

Kopin is expanding microLED manufacturing in Westborough, Massachusetts, which could add up to 80 jobs over five years. Its microLEDs will go to military displays and to Neural I/o, an interconnect that sends AI data as light. In the same news round-up, Q.ANT and IONOS opened a photonic processor pilot where approved applicants can run their own workloads.

  • 01Two photonic approaches tied to AI’s power problem reached testable hardware this month: PsiQuantum’s 8×8 optical switch samples and Q.ANT’s second-generation processor via an IONOS bare-metal pilot in Germany.
  • 02PsiQuantum is sending samples of an 8×8 demonstration optical circuit switch to selected prospective customers, giving buyers hardware they can test even though commercial products and full specs are still pending.
  • 03Staffing may not keep up with demand: a 2023 Applied Optics study projected US demand for 42,000 new middle-skilled photonics workers by 2030, and Kopin’s expansion adds another competitor for photonics technicians in Massachusetts.

Nov 15, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512